Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM)
- Resource Type
- Journal
- Authors
- Garfall, Alfred L.; Usmani, Saad Z.; Mateos, Maria-Victoria; Nahi, Hareth; van de Donk, Niels W. C. J.; San-Miguel, Jesus F.; Rocafiguera, Albert Oriol; Rosinol, Laura; Chari, Ajai; Bhutani, Manisha; Pei, Lixia; Verona, Raluca; Girgis, Suzette; Stephenson, Tara; Goldberg, Jenna D.; Banerjee, Arnob; Krishnan, Amrita
- Source
- BLOOD; NOV 5 2020, 136 4p. Supplement: 1
- Subject
- Language
- English
- ISSN
- 15280020